Macleods Pharmaceuticals is recalling two products in the U.S. market for deviations from standard manufacturing practices.

According to the latest enforcement report from the U.S. Food and Drug Administration (USFDA), the U.S.-based division of the pharmaceutical company has recalled the following:

3,672 amlodipine and olmesartan medoxomil tablets are used to treat high blood pressure.

New Jersey-based Macleods Pharma USA Inc is recalling affected batches due to “eCGMP (current Good Manufacturing Practice) discrepancies,” according to U.S. health officials.

Click for more on Drug Recall

According to the USFDA, a Class II recall is a situation in which use or exposure to an infringing product may cause temporary or medically reversible adverse health effects, or situations in which serious adverse health effects are unlikely.

The batch was manufactured by his Mumbai-based Macleods Pharmaceuticals at its manufacturing facility in Badi, HP.

Click for more on USFDA

On February 15, 2015, the company started a second-class recall on a nationwide scale. Macleods is also recalling a number of olanzapine tablets used to treat schizophrenia in the US market.

The USFDA noted that it is also recalling affected batches due to eCGMP discrepancies.

The company manufactured the affected batch at its Buddy facility and later commercialized it in the U.S. market by McLeods Pharma USA Inc. The company initiated a Type 2 voluntary recall on February 16, 2022.

Click for more on Macleods Pharmaceuticals

The company manufactures a wide range of formulations in multiple dosage forms, including oral solids (tablets and capsules, including soft gelatin capsules), oral liquids, dry syrups, topical agents, granules, inhalers and aerosols, and injectables. doing. The company has a presence in different countries, such as the USA, the UK, and Spain.

Other drugs recall

Drug recall: Acyclovir Sodium Injection recalled due to this reason

Drug recall: Zydus, Lupin recall products due to this issue

Drug recall: Glenmark, Strides Pharma, Cipla recalled these drugs

Drug recall: Glenmark, Sun, Dr Reddy’s recalled these Drugs

Drug recall: Atorvastatin 40 mg tablets recalled due to this reason

Drug recall: Magnesium Citrate Oral Solution recalled due to this reason

Govt begins anti-dumping probe against antibiotic Metronidazole imported from China

NPPA extends price revision of Heparin injection, LMO and Oxygen inhalation

This eye drop might replace reading glasses soon

Govt introduces registration certificate for sales of Medical Devices

USFDA gives final approval for Brivaracetam tablets

Unichem recalls 18,960 bottles of this hypertension drug

Doctors urge FDA to add miscarriage management to abortion pill label

NPPA fixes Retail Prices of 40 Formulations: September 2022

IPC launches 1000th IP Reference Standard

NDPS: Inter-state Pharmaceutical drug racket busted

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/?p=41547